Team:Freiburg

From 2013.igem.org

(Difference between revisions)
Line 1: Line 1:
{{Template:Freiburg2013_Template1}}
{{Template:Freiburg2013_Template1}}
-
{{Template:Freiburg2013_Script}}
+
 
<html>
<html>
<head>
<head>
Line 10: Line 10:
<script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.2/jquery.min.js"></script>
<script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.2/jquery.min.js"></script>
<!-- bxSlider Javascript file -->
<!-- bxSlider Javascript file -->
-
<script src="jquery.bxslider.min.js"></script>
+
<script src="https://2013.igem.org/Template:Freiburg2013_Script"></script>
<!-- bxSlider CSS file -->
<!-- bxSlider CSS file -->
<link href="jquery.bxslider.css" rel="stylesheet" />
<link href="jquery.bxslider.css" rel="stylesheet" />

Revision as of 13:49, 27 August 2013

Gene Regulation – Multiple Targets – Activation – Optogenetics – Repression – Inducibility – Epigenetics

Just imagine there was a tool that combined all these aspects of lab work. A tool, that was able to rule several genes at once; a tool that allowed highly specific gene modulation via stimulus induction; a tool that would be a new approach to gene regulation.

This year’s Freiburg iGEM Team uses the prokaryotic CRISPR/Cas system to enable multiple endogenous gene regulation with minimal effort. The regulation is based on a protein-RNA-DNA interaction. Customizable RNAs function as a guide for our protein in order to target specific DNA sequences. By fusing effector domains to this protein, we aim at developing a tool for multiple and inducible gene activation and repression. Despite the system's prokaryotic origin, gene target sequences are adjustable for various organisms, offering a broad application variety of our tool. Due to its great potential, the CRISPR/Cas system has become of increasing importance in current research and can be implemented in a number of novel and interesting applications, such as gene therapy or tissue engineering.